Literature DB >> 557765

Agarose electrophoresis of cerebrospinal fluid in multiple sclerosis. A simplified method for demonstrating cerebrospinal fluid oligoclonal immunoglobulin bands.

K P Johnson, S C Arrigo, B J Nelson, A Ginsberg.   

Abstract

The gamma globulins in cerebrospinal fluid from almost all patients with multiple sclerosis migrate in agarose electrophoresis as abnormal discrete populations, so-called oligoclonal bands. Such bands have also appeared in cerebrospinal fluid from patients with other types of inflammatory pathology such as neurosyphilis, acute idiopathic polyneuropathy, and subacute sclerosing panencephalitis. The demonstration of cerebrospinal fluid oligoclonal bands may aid in the evaluation of patients with early or atypical multiple sclerosis. This report describes a simple method for demonstrating cerebrospinal fluid oligoclonal bands using readily available commercial reagents and apparatus. Oligoclonal bands were seen in cerebrospinal fluid from all patients with clinically definite multiple sclerosis, even though some had normal cerebrospinal fluid gamma globulin levels, and in most patients with presumptive multiple sclerosis or other inflammatory conditions of the nervous system. They were not seen in cerebrospinal fluid of control patients with a variety of other neurologic diseases.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 557765     DOI: 10.1212/wnl.27.3.273

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

1.  Multiple sclerosis: new techniques in earlier diagnosis.

Authors:  W J Hader
Journal:  Can Fam Physician       Date:  1983-01       Impact factor: 3.275

2.  Viral antibodies in cerebrospinal fluid of multiple sclerosis and control patients: comparison between radioimmunoassay and conventional techniques.

Authors:  B Forghani; N E Cremer; K P Johnson; A H Ginsberg; W H Likosky
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

3.  Polyreactive myelin oligodendrocyte glycoprotein antibodies: Implications for systemic autoimmunity in progressive experimental autoimmune encephalomyelitis.

Authors:  Lisa K Peterson; Ikuo Tsunoda; Takahisa Masaki; Robert S Fujinami
Journal:  J Neuroimmunol       Date:  2007-01-02       Impact factor: 3.478

4.  Oligoclonal banding in the cerebrospinal fluid of patients with postencephalitic Parkinsonism.

Authors:  A Williams; S Houff; A Lees; D B Calne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-09       Impact factor: 10.154

5.  Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein.

Authors:  Kevin C O'Connor; Heiner Appel; Lisa Bregoli; Matthew E Call; Ingrid Catz; Jennifer A Chan; Nicole H Moore; Kenneth G Warren; Susan J Wong; David A Hafler; Kai W Wucherpfennig
Journal:  J Immunol       Date:  2005-08-01       Impact factor: 5.422

6.  Detection of IgG oligoclonal bands in unconcentrated CSF by means of agarose isoelectric focusing, double immunofixation peroxidase staining and avidin-biotin amplification.

Authors:  P Gallo; F Bracco; L Battistin; B Tavolato
Journal:  Ital J Neurol Sci       Date:  1985-09

7.  CFS oligoclonal bands in MS and other neurological diseases detected by agarose isoelectric focusing and electrophoresis.

Authors:  D Cerrato; A Salmaggi; C Ariano; L La Mantia; A Nespolo
Journal:  Ital J Neurol Sci       Date:  1984-09

8.  Relation between benign course of multiple sclerosis and low-grade humoral immune response in cerebrospinal fluid.

Authors:  L Stendahl-Brodin; H Link
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-02       Impact factor: 10.154

9.  Oligoclonal immunoglobulins in subacute sclerosing panencephalitis and multiple sclerosis: a study of idiotypic determinants.

Authors:  G C Ebers; J B Zabriskie; H G Kunkel
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

10.  Progressive rubella panencephalitis: immunovirological studies and results of isoprinosine therapy.

Authors:  J S Wolinsky; P C Dau; E Buimovici-Klein; J Mednick; B O Berg; P B Lang; L Z Cooper
Journal:  Clin Exp Immunol       Date:  1979-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.